Downstream Hatch-Waxman: Unforeseen IP Ramifications
Litigation challenging patents on branded drugs has increased exponentially since the passage of the Drug Price Competition and Patent Term Restoration Act of 1984 (commonly referred to as the "Hatch Waxman...To view the full article, register now.
Already a subscriber? Click here to view full article